Literature DB >> 33348262

Antibacterial, proangiogenic, and osteopromotive nanoglass paste coordinates regenerative process following bacterial infection in hard tissue.

Jung Ju Seo1, Nandin Mandakhbayar2, Min Sil Kang1, Ji-Young Yoon2, Na-Hyun Lee2, Junyong Ahn3, Hae-Hyoung Lee3, Jung-Hwan Lee4, Hae-Won Kim5.   

Abstract

Bacterial infection raises serious concerns in tissue repair settings involved with implantable biomaterials, devastating the regenerative process and even life-threatening. When hard tissues are infected with bacteria (called 'osteomyelitis'), often the cases in open fracture or chronic inflammation, a complete restoration of regenerative capacity is significantly challenging even with highly-dosed antibiotics or surgical intervention. The implantable biomaterials are thus needed to be armored to fight bacteria then to relay regenerative events. To this end, here we propose a nanoglass paste made of ~200-nm-sized silicate-glass (with Ca, Cu) particles that are hardened in contact with aqueous medium and multiple-therapeutic, i.e., anti-bacterial, pro-angiogenic and osteopromotive. The nanoglass paste self-hardened via networks of precipitated nano-islands from leached ions to exhibit ultrahigh surface area (~300 m2/g), amenable to fill tunable defects with active biomolecular interactions. Also, the nanoglass paste could release multiple ions (silicate, calcium, and copper) at therapeutically relevant doses and sustainably (for days to weeks), implying possible roles in surrounding cells/tissues as a therapeutic-ions reservoir. The osteopromotive effects of nanoglass paste were evidenced by the stimulated osteogenic differentiation of MSCs. Also, the nanoglass paste promoted angiogenesis of endothelial cells in vitro and vasculature formation in vivo. Furthermore, the significant bactericidal effect of nanoglass paste, as assessed with E. coli and S. aureus, highlighted the role of copper played in elevating ROS level and destroying homeostasis, which salvaged tissue cells from co-cultivated bacteria contamination. When administered topically to rat tibia osteomyelitis defects, the nanoglass paste enhanced in vivo bone healing and fracture resistance. The developed nanoglass paste, given its self-setting property and the coordinated therapeutic actions, is considered to be a promising drug-free inorganic biomaterial platform for the regenerative therapy of bacteria-infected hard tissues.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bactericidal; Nanoglass paste; Osteomyelitis; Osteopromotive; Pro-angiogenic; Therapeutic actions

Year:  2020        PMID: 33348262     DOI: 10.1016/j.biomaterials.2020.120593

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

Review 1.  New Prospects in Nano Phased Co-substituted Hydroxyapatite Enrolled in Polymeric Nanofiber Mats for Bone Tissue Engineering Applications.

Authors:  Kareem E Mosaad; Kamel R Shoueir; Ahmed H Saied; Montasser M Dewidar
Journal:  Ann Biomed Eng       Date:  2021-08-10       Impact factor: 3.934

Review 2.  Strontium Functionalized in Biomaterials for Bone Tissue Engineering: A Prominent Role in Osteoimmunomodulation.

Authors:  Jiaqian You; Yidi Zhang; Yanmin Zhou
Journal:  Front Bioeng Biotechnol       Date:  2022-07-06

3.  Preparation of multigradient hydroxyapatite scaffolds and evaluation of their osteoinduction properties.

Authors:  Hao Huang; Anchun Yang; Jinsheng Li; Tong Sun; Shangke Yu; Xiong Lu; Tailin Guo; Ke Duan; Pengfei Zheng; Jie Weng
Journal:  Regen Biomater       Date:  2022-02-01

Review 4.  Biomineralization of bone tissue: calcium phosphate-based inorganics in collagen fibrillar organic matrices.

Authors:  Min-Ho Hong; Jung Heon Lee; Hyun Suk Jung; Heungsoo Shin; Hyunjung Shin
Journal:  Biomater Res       Date:  2022-09-06

5.  Characterization of Physical and Biological Properties of a Caries-Arresting Liquid Containing Copper Doped Bioglass Nanoparticles.

Authors:  Se-Jung Bang; Soo-Kyung Jun; Yu-Jin Kim; Jun-Yong Ahn; Huong Thu Vu; Nandin Mandakhbayar; Mi-Ran Han; Jun-Haeng Lee; Jong-Bin Kim; Jong-Soo Kim; Jonathan C Knowles; Hye-Sung Kim; Hae-Hyoung Lee; Ji-Sun Shin; Jung-Hwan Lee
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.